Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2014 (2014), Article ID 939053, 7 pages
http://dx.doi.org/10.1155/2014/939053
Research Article

Ventral Prostate Fibrosis in the Akita Mouse Is Associated with Macrophage and Fibrocyte Infiltration

1Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53717, USA
2Cellular and Molecular Biology Program, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI 53706, USA
3Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI 53717, USA

Received 15 November 2013; Accepted 23 April 2014; Published 11 June 2014

Academic Editor: Bernard Portha

Copyright © 2014 Sanghee Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Bushman, “Etiology, epidemiology, and natural history,” Urologic Clinics of North America, vol. 36, no. 4, pp. 403–415, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Ma, M. Gharaee-Kermani, L. Kunju et al., “Prostatic fibrosis is associated with lower urinary tract symptoms,” The Journal of Urology, vol. 188, no. 4, pp. 1375–1381, 2012. View at Publisher · View at Google Scholar
  3. E. Bercovich, G. Barabino, F. Pirozzi-Farina, and M. Deriu, “A multivariate analysis of lower urinary tract ageing and urinary symptoms: the role of fibrosis,” Archivio Italiano di Urologia, Andrologia, vol. 71, no. 5, pp. 287–292, 1999. View at Google Scholar · View at Scopus
  4. J. K. Parsons, H. Ballentine, A. W. Partin et al., “Metabolic factors associated with benign prostatic hyperplasia,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 7, pp. 2562–2568, 2006. View at Publisher · View at Google Scholar
  5. Y. Sugimura, G. R. Cunha, and A. A. Donjacour, “Morphogenesis of ductal networks in the mouse prostate,” Biology of Reproduction, vol. 34, no. 5, pp. 961–971, 1986. View at Google Scholar · View at Scopus
  6. D. Zechner, N. Knapp, A. Bobrowski, T. Radecke, B. Genz, and B. Vollmar, “Diabetes increases pancreatic fibrosis during chronic inflammation,” Experimental Biology and Medicine. In press.
  7. B. J. Boehm, S. A. Colopy, T. J. Jerde, C. J. Loftus, and W. Bushman, “Acute bacterial inflammation of the mouse prostate,” Prostate, vol. 72, no. 3, pp. 307–317, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Nagano, M. Shimizu, T. Hara et al., “Effects of indoleamine 2, 3-dioxygenase deficiency on high-fat diet-induced hepatic inflammation,” PLoS ONE, vol. 8, no. 9, Article ID e73404, 2013. View at Publisher · View at Google Scholar
  9. T. R. Cox, D. Bird, A.-M. Baker et al., “LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis,” Cancer Research, vol. 73, no. 6, pp. 1721–1732, 2013. View at Publisher · View at Google Scholar
  10. T. A. Wynn, “Cellular and molecular mechanisms of fibrosis,” Journal of Pathology, vol. 214, no. 2, pp. 199–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. W. McKleroy, T. H. Lee, and K. Atabai, “Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 304, no. 11, pp. L709–L721, 2013. View at Publisher · View at Google Scholar
  12. D. L. Ribeiro, E. J. Caldeira, E. M. Cândido, A. J. Manzato, S. R. Taboga, and V. H. Cagnon, “Prostatic stromal microenvironment and experimental diabetes,” European Journal of Histochemistry, vol. 50, no. 1, pp. 51–60, 2006. View at Google Scholar · View at Scopus
  13. D. L. Ribeiro, S. R. Taboga, and R. M. Góes, “Diabetes induces stromal remodelling and increase in chondroitin sulphate proteoglycans of the rat ventral prostate,” International Journal of Experimental Pathology, vol. 90, no. 4, pp. 400–411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. V. H. A. Cagnon, A. M. Camargo, R. M. Rosa, R. Fabiani, C. R. Padovani, and F. E. Martinez, “Ultrastructural study of the ventral lobe of the prostate of mice with streptozotocin induced diabetes (C57BL/6J),” Tissue and Cell, vol. 32, no. 4, pp. 275–283, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. G. L. Powers and P. C. Marker, “Recent advances in prostate development and links to prostatic diseases,” Wiley Interdisciplinary Reviews: Systems Biology and Medicine, vol. 5, no. 2, pp. 243–256, 2013. View at Google Scholar
  16. M. Gharaee-Kermani, J. A. Rodriguez-Nieves, R. Mehra et al., “Obesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse model,” The Prostate, vol. 73, no. 10, pp. 1123–1133, 2013. View at Publisher · View at Google Scholar
  17. Y. Sugimura, M. Sakurai, N. Hayashi, A. Yamashita, and J. Kawamura, “Age-related changes of the prostate gland in the senescence-accelerated mouse,” The Prostate, vol. 24, no. 1, pp. 24–32, 1994. View at Google Scholar · View at Scopus
  18. C. L. Lin, “Cannabinoid receptor 1 disturbance of PPARgamma2 augments hyperglycemia induction of mesangial inflammation and fibrosis in renal glomeruli,” Journal of Molecular Medicine. In press.
  19. Y. Liu, Y. Wang, X. Miao et al., “Inhibition of JNK by compound C66 prevents pathological changes of the aorta in STZ-induced diabetes,” Journal of Cellular and Molecular Medicine, 2014. View at Publisher · View at Google Scholar
  20. S. P. Hartono, B. E. Knudsen, L. O. Lerman et al., “Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice,” BMC Nephrology, vol. 15, no. 1, article 58, 2014. View at Publisher · View at Google Scholar
  21. Y. Wang, Z. Zhang, W. Sun et al., “Sulforaphane attenuation of type 2 diabetes-induced aortic damage was associated with the upregulation of nrf2 expression and function,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 123963, 11 pages, 2014. View at Publisher · View at Google Scholar
  22. S. P. Cartland, J. H. Erlich, and M. M. Kavurma, “TRAIL deficiency contributes to diabetic nephropathy in fat-fed ApoE-/- mice,” PLoS ONE, vol. 9, no. 3, Article ID e92952, 2014. View at Google Scholar
  23. V. Delghingaro-Augusto, L. Madad, A. Chandra et al., “Islet inflammation, hemosiderosis, and fibrosis in intrauterine growth-restricted and high fat-fed sprague-dawley rats,” The American Journal of Pathology, vol. 184, no. 5, pp. 1446–1457, 2014. View at Publisher · View at Google Scholar
  24. S. M. Morris Jr., T. Gao, T. K. Cooper, D. Kepka-Lenhart, and A. S. Awad, “Arginase-2 mediates diabetic renal injury,” Diabetes, vol. 60, no. 11, pp. 3015–3022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Y. Chow, D. J. Nikolic-Paterson, R. C. Atkins, and G. H. Tesch, “Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis,” Nephrology Dialysis Transplantation, vol. 19, no. 12, pp. 2987–2996, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Proctor, T. Jiang, M. Iwahashi, Z. Wang, J. Li, and M. Levi, “Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes,” Diabetes, vol. 55, no. 9, pp. 2502–2509, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. R. A. Reilkoff, R. Bucala, and E. L. Herzog, “Fibrocytes: emerging effector cells in chronic inflammation,” Nature Reviews Immunology, vol. 11, no. 6, pp. 427–435, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. J. A. Rodriguez-Nieves and J. A. Macoska, “Prostatic fibrosis, lower urinary tract symptoms, and BPH,” Nature Reviews Urology, vol. 10, no. 9, pp. 546–550, 2013. View at Google Scholar
  29. F. Cantiello, A. Cicione, A. Salonia et al., “Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study,” Urology, vol. 81, no. 5, pp. 1018–1023, 2013. View at Publisher · View at Google Scholar